Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
06.07.2017 23:30:00

Top Leadership of ViaSat, ResMed, Qualcomm, DLA Piper join EvoNexus Board of Directors

SAN DIEGO, July 6, 2017 /PRNewswire/ --Richard Baldridge, President & COO, ViaSat (NASDAQ: VSAT) was elected Chairman of the Board of Directors of EvoNexus. Mr. Baldridge leads corporate strategy and operations for ViaSat, a global provider of satellite broadband and wireless services, infrastructure, and technology. During his tenure, ViaSat has grown organically and through acquisitions by more than a factor of 10, to a multi-billion dollar enterprise. 

Rob Douglas, President & COO, ResMed (NYSE: RMD) was elected Vice Chairman of the Board of Directors of EvoNexus. ResMed is a global medical device company in the treatment of Sleep Disorder Breathing. Mr. Douglas, a leader in the life science industry, has over 25 years experience in operations and marketing for high-tech medical device and e-commerce solution sector leaders.

Derek Aberle, President of Qualcomm Incorporated (NASDAQ: QCOM) was elected to the EvoNexus Board of Directors. As president of Qualcomm, Mr. Aberle as a member of Qualcomm's executive committee since 2008, helped drive Qualcomm's overall global strategy and in recent years has been instrumental to evolving and expanding Qualcomm's business in China, including leading negotiations with the Chinese Government and establishing important new business ventures in China.

DLA Piper has also taken a board seat at EvoNexus with the election of senior partner, Larry Nishnick. Larry's recent representation of public and private companies includes Qualcomm, ViaSat, Provide Commerce, Jack-in-the-Box, Cross-Fit, NuVasive Life Technologies, Cypher Genomics, Halozyme Therapeutics, and a vast number of private emerging growth technology companies.

"EvoNexus is fortunate to have this leadership and the finest Board of Directors of any incubator in the entire country. Their financial and strategic support of the ventures launched and their dedication to the mission of EvoNexus is impacting the growth of the innovation economy," said EvoNexus CEO and co-founder, Rory Moore. "The integration of new technologies into markets is accelerated when established corporations partner with startup communities."

EvoNexus is a non-profit technology incubator with locations in San Diego and Irvine. Under its model, EvoNexus startups receive mentorship, access to capital, and full services without giving up equity or paying fees. Its startups enjoy Class A office and lab space provided by California's leading real estate developer, The Irvine Company. EvoNexus is supported by corporations, including some of the largest multinational corporations in the world. In just over 7 years, EvoNexus portfolio companies have raised over $1.19 billion in funding and outcomes and 18 startups have been acquired.

For more information, visit
Acquisitions: https://evonexus.org/startup-success-stories/ 
Partnering: https://evonexus.org/join/sponsorship-partnership/ 
Investing: https://evonexus.org/evonexus/companies/ 
Applying: https://evonexus.org/apply/ 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/top-leadership-of-viasat-resmed-qualcomm-dla-piper-join-evonexus-board-of-directors-300484414.html

SOURCE EvoNexus

Analysen zu ViaSat Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

QUALCOMM Inc. 149,46 0,42% QUALCOMM Inc.
ResMed Inc. 228,50 0,13% ResMed Inc.
ViaSat Inc. 7,92 21,90% ViaSat Inc.